Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
Open Access
- 1 June 1994
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (6) , 2505-2513
- https://doi.org/10.1172/jci117260
Abstract
Three laboratory workers have been infected with the IIIB strain of HIV; their antibody response to HIV has been studied in serial serum specimens. Because the infecting virus is known, the fine specificity of the antibody response was studied on the homologous strain of HIV. Anti-p17, anti-p24, anti-gp160, CD4/gp120 blocking and neutralizing antibodies developed in parallel. Epitope mapping of the anti-gp160 response indicated several regions that consistently induced an antibody response. Serum contained antibody which reacted with V3-specific peptides corresponding to the very tip of the loop and crossreactivity was seen with V3 loop peptides from other sequence divergent strains of HIV. Antibody to the V1 loop was produced at levels comparable with that seen for the V3-loop. Anti-V1 neutralized HIV with a titration curve equivalent to an anti-V3 monoclonal antibody. Because the infecting virus is known and serial reisolates have been obtained, we explored the relationship between production of antibody to a given epitope and mutation in the virus. The data suggest that an association exists, but do not clearly indicate that antibody drives the selection for mutant viruses. The findings presented here provide a fine specificity analysis of the evolution of the antibody response to HIV in greater detail than has previously been performed.Keywords
This publication has 25 references indexed in Scilit:
- Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.The Journal of Experimental Medicine, 1990
- Association of antibodies blocking HIV-1 gp160-sCD4 attachment with virus neutralizing activity in human seraJournal of Medical Virology, 1990
- Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.The Journal of Immunology, 1990
- Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Proceedings of the National Academy of Sciences, 1989
- Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope geneCell, 1988
- Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.Proceedings of the National Academy of Sciences, 1988
- Quantitative infectivity assay for HIV-1 and -2Nature, 1988
- Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptorCell, 1987
- Strategies for epitope analysis using peptide synthesisJournal of Immunological Methods, 1987
- Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular cloneJournal of Virology, 1986